Navigation Links
Bioenergy Introduces Corvalen M(R) as a Natural Treatment Option for Fibromyalgia Symptoms

MINNEAPOLIS, May 27 /PRNewswire/ -- Fibromyalgia affects as many as one in 50 Americans, 90 percent of whom are women. Yet, despite its nearly epidemic status, patients still often rely on pharmaceutical options solely for treatment. That's why Bioenergy Life Science, Inc. ( has introduced Corvalen M®, a natural treatment option for fibromyalgia symptoms.  

Fibromyalgia is a syndrome mainly associated with widespread muscular pains and fatigue. The exact causes of fibromyalgia are unknown; however, patients with fibromyalgia have been shown to have an alteration in muscle adenine nucleotide metabolism, leading to depleted energy reserves (1).  As an essential compound in increasing muscular energy pools and reducing metabolic strain in affected muscles, Corvalen M® has been shown to be effective against fibromyalgia symptoms (2).

Corvalen M® comprises D-Ribose, a simple, 5-carbon monosaccharide, or pentose sugar. D-Ribose helps accelerate the formation of adenosine triphosphate (ATP), the primary energy source of all living cells, which can lead to subsequent tissue recovery for fibromyalgia patients.

"Having had Chronic Fatigue Syndrome and Fibromyalgia back in 1975, I know what patients are going through," says Dr. Jacob Teitelbaum, M.D, one of the primary researchers of this study and the medical director of the Fibromyalgia and Fatigue Centers, Inc. "The good news is these illnesses have become very treatable!"

Teitelbaum conducted a multi-center study, in which 53 health practitioners enrolled 257 patients who had been diagnosed with fibromyalgia and/or chronic fatigue syndrome. Each patient was given D-Ribose (Corvalen) at a dose of five grams per day for three weeks. All patients were measured for changes in energy, sleep, cognitive function, pain and overall well-being.

Teitelbaum noted improvement in the first week of treatment. After three weeks, results showed statistically significant improvements in all five parameters, More than half of the study's patients showed improvement in energy (61 percent), followed by a 37 percent increase in overall well-being.  

Bioenergy Life Science, Inc. focuses its core technology on D-Ribose®, the primary ingredient in the Corvalen Medical Food family of products, which include Corvalen®, Corvalen M® and Corvalen® Chewable Wafers. D-Ribose® is the only ribose to receive GRAS (generally regarded as safe) affirmation, no questions letter from the Food and Drug Administration (FDA). D-Ribose® is found also in many energy drinks, bars and supplements.

For more information, contact Renee Cooper of Christie Communications at 805-969-3744 or

(1)  Gebhart B, Jorgenson JA. Benefit of ribose in a patient with fibromyalgia. Pharmacotherapy. 2004 Nov;24(11):1646-8

(2)  Teitelbaum J, Johnson C, Cyr J. The Use of D-Ribose in Chronic Fatigue Syndrome and Fibromyalgia: A Pilot Study. The Journal of Alternative and Complementary Medicine. 2006 12(9):857-862

SOURCE Bioenergy Life Science, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Bersin & Associates Introduces New Talent Management Framework
2. Varian Medical Systems Introduces ProBeam(TM) Proton Therapy Platform at Particle Therapy Co-operative Group (PT COG) 2010 Meeting
3. Ambry Genetics Introduces AmbryScreen(TM), a Genetic Test Screening for Some of the Most Common and Severe Genetic Disorders Affecting Newborns.
4. Ethicon Endo-Surgery Introduces Two New Staplers for Open Surgical Procedures at ASCRS
5. Biosense Webster Introduces the THERMOCOOL(R) SF Irrigated Catheter in the European Union
6. Ethicon Endo-Surgery Introduces HARMONIC FOCUS(R) Long Curved Shears for Deep Surgical Access
7. MAQUET Cardiovascular Introduces New VASOSHIELD Pressure Controlling Syringe to Help Preserve Graft Integrity for Coronary Artery Bypass Surgery Patients
8. Burton Medical Introduces the AIM-200(R) as a Versatile, Long-Lasting Light Source for Ambulatory Surgical Centers
9. Sikorsky Global Helicopters Introduces State-of-the-Art Emergency Medical Services Interior for S-76(R) Helicopter
10. Samplify Introduces New Compression Technology to Lower Costs for Mobile Operators Migrating to 4G
11. Bayer Diabetes Care Introduces DIDGET In the US
Post Your Comments:
(Date:10/13/2015)... , Oct. 13 2015 ... addition of the "US & European ... Countries (2010-2021)" report to their offering. ... the addition of the "US & ... 16 Countries (2010-2021)" report to their ...
(Date:10/13/2015)... -- Graduate students across the country, with an interest ... have the opportunity to learn about a lesser-known ... and development process. Eli Lilly and Company (NYSE: ... from academic institutions to create an elective graduate ... Development."  Lilly will formally unveil the eLearning course ...
(Date:10/13/2015)... WuXi PharmaTech (Cayman) Inc. (NYSE:  WX), a ... serving the pharmaceutical, biotechnology, and medical device industries, ... version of OncoWuXi, the first App in the ... and data on the go.  The OncoWuXi App ... to identify relevant tumor models for use in ...
Breaking Medicine Technology:
(Date:10/13/2015)... California (PRWEB) , ... October ... ... launched Postnatal Omega-3, a first-of-its kind product that targets the unique health ... Postnatal Omega-3” of the American Pregnancy Association ( ), utilizes Nordic ...
(Date:10/13/2015)... ... October 13, 2015 , ... T-System and Centegra Health ... 59,000 emergency department visits per year, today announced the successful and rapid deployment ... clinical, operational and financial outcomes. , In less than four days, ...
(Date:10/13/2015)... ... October 13, 2015 , ... Tempe Dental Care, a leading Tempe dentists’ office, ... IV sedation dentistry for more than 5 years. A leading cause of emergency ... painful if treatment is not timely. , Sedation dentistry provides an ...
(Date:10/13/2015)... ... 2015 , ... World Patent Marketing , a vertically integrated manufacturer and ... helps people in clearing snow away from the streets and driveways. , "The Snowplowing ... year," says Scott Cooper, CEO and Creative Director of World Patent Marketing and ...
(Date:10/13/2015)... ... October 13, 2015 , ... According to an ESPN report published ... a teammate accidentally elbowed him in the left eye during the first day of ... one of a series of setbacks, including a knee injury that has interfered with ...
Breaking Medicine News(10 mins):